Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01+0.03 (+3.30%)
Close on Nov 17, 2026Market cap $19.46MP/E –Yield –
Cocrystal Pharma total assets
Total assets on the balance sheet at the end of each period.
Cocrystal Pharma's total assets was $4.65M at Jun 30, 2026. For fiscal 2025 it was $9.71M, down 27.8% from the year before. Over ten years it grew -26.9% a year on average. The highest annual figure on record is $259.28M in fiscal 2014.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.71M | -27.8% |
| FY2024 | Dec 31, 2024 | $13.46M | -57.0% |
| FY2023 | Dec 31, 2023 | $31.26M | -23.5% |
| FY2022 | Dec 31, 2022 | $40.84M | -48.6% |
| FY2021 | Dec 31, 2021 | $79.39M | +46.4% |
| FY2020 | Dec 31, 2020 | $54.24M | +90.1% |
| FY2019 | Dec 31, 2019 | $28.53M | -58.4% |
| FY2018 | Dec 31, 2018 | $68.56M | -43.5% |
| FY2017 | Dec 31, 2017 | $121.43M | -2.8% |
| FY2016 | Dec 31, 2016 | $124.88M | -44.3% |
| FY2015 | Dec 31, 2015 | $224.23M | -13.5% |
| FY2014 | Dec 31, 2014 | $259.28M | +15510.1% |
| FY2013 | Dec 31, 2013 | $1.66M | -77.1% |
| FY2012 | Dec 31, 2012 | $7.24M | -4.1% |
| FY2011 | Dec 31, 2011 | $7.55M | +0.2% |
| FY2010 | Dec 31, 2010 | $7.53M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.65M | -45.3% |
| Q1 FY2026 | Mar 31, 2026 | $7.43M | -30.3% |
| Q4 FY2025 | Dec 31, 2025 | $9.71M | -27.8% |
| Q3 FY2025 | Sep 30, 2025 | $10.45M | -35.6% |
| Q2 FY2025 | Jun 30, 2025 | $8.51M | -60.6% |
| Q1 FY2025 | Mar 31, 2025 | $10.66M | -59.8% |
| Q4 FY2024 | Dec 31, 2024 | $13.46M | -57.0% |
| Q3 FY2024 | Sep 30, 2024 | $16.23M | -50.2% |
| Q2 FY2024 | Jun 30, 2024 | $21.57M | -40.5% |
| Q1 FY2024 | Mar 31, 2024 | $26.55M | -29.8% |
| Q4 FY2023 | Dec 31, 2023 | $31.26M | -23.5% |
| Q3 FY2023 | Sep 30, 2023 | $32.61M | -28.6% |
| Q2 FY2023 | Jun 30, 2023 | $36.28M | -30.7% |
| Q1 FY2023 | Mar 31, 2023 | $37.84M | -49.8% |
| Q4 FY2022 | Dec 31, 2022 | $40.84M | -48.6% |
| Q3 FY2022 | Sep 30, 2022 | $45.65M | -44.7% |
| Q2 FY2022 | Jun 30, 2022 | $52.38M | -40.1% |
| Q1 FY2022 | Mar 31, 2022 | $75.37M | +40.0% |
| Q4 FY2021 | Dec 31, 2021 | $79.39M | +46.4% |
| Q3 FY2021 | Sep 30, 2021 | $82.60M | +55.2% |
| Q2 FY2021 | Jun 30, 2021 | $87.42M | +116.0% |
| Q1 FY2021 | Mar 31, 2021 | $53.85M | +25.7% |
| Q4 FY2020 | Dec 31, 2020 | $54.24M | +90.1% |
| Q3 FY2020 | Sep 30, 2020 | $53.22M | -27.5% |
| Q2 FY2020 | Jun 30, 2020 | $40.48M | -46.0% |
| Q1 FY2020 | Mar 31, 2020 | $42.84M | -43.8% |
| Q4 FY2019 | Dec 31, 2019 | $28.53M | -58.4% |
| Q3 FY2019 | Sep 30, 2019 | $73.44M | -40.9% |
| Q2 FY2019 | Jun 30, 2019 | $74.91M | -40.7% |
| Q1 FY2019 | Mar 31, 2019 | $76.29M | -36.8% |
| Q4 FY2018 | Dec 31, 2018 | $68.56M | -43.5% |
| Q3 FY2018 | Sep 30, 2018 | $124.17M | +1.6% |
| Q2 FY2018 | Jun 30, 2018 | $126.33M | +1.6% |
| Q1 FY2018 | Mar 31, 2018 | $120.72M | -1.5% |
| Q4 FY2017 | Dec 31, 2017 | $121.43M | -2.8% |
| Q3 FY2017 | Sep 30, 2017 | $122.25M | -44.7% |
| Q2 FY2017 | Jun 30, 2017 | $124.34M | – |
| Q1 FY2017 | Mar 31, 2017 | $122.52M | – |
| Q4 FY2016 | Dec 31, 2016 | $124.88M | – |
| Q3 FY2016 | Sep 30, 2016 | $220.90M | – |
See a number that looks wrong?